The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

Follow-Up Studies of Lithium and Thyroid Function in Manic-Depressive Illness

Published Online:https://doi.org/10.1176/ajp.125.10.1443

In an earlier study the authors reported that six out of 19 manic-depressive patients treated with lithium showed evidence of goiter, suggesting that lithium may have goitrogenic properties. They now report the finding of a similar incidence of goiter among 13 patients treated with imipramine. They conclude that three explanations are possible: the incidence of goiter among the general population might be equally high if EAI scanning instead of palpation were used routinely; the incidence of goiter detected among the two groups of patients studied may be a result of various drug treatments, periodic hospitalizations, and dietary insufficiencies; or it may be related to some characteristic of manic-depressive disease.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.